Although spin-echo techniques are often used to obtain 1H..NMRspectra of serum or plasma samples, they do not provide reliable quantitative analyses of metabolites. We present a standardized procedure, optimized for sensitivity, for using single-pulse 1H-NMR spectroscopy to analyze deproteinized plasma. The detection limitfor various metabolites ranges between 2 and 40 mol/L. The method allows quantitative analysis of many compounds of interest in studies of inborn errors of metabolism, including betaine and dimethyiglycine, which cannot be measured easily with other techniques. For lactate, tyrosine, threonine, and alanine, we obtained results that correlated well with those obtained by established techniques. We also present a library containing resonance positions of 38 compounds occurring in plasma samples in health and disease, including 14 as-yet-unidentifIed resonances. As an example of the diagnosticpower of the technique we show a spectrum of a plasma sample from a patient with 5-oxoprolinuria (pyroglutamic aciduria; McKusick 266130), an enzymatic defect in glutathione biosynthesis.
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IndexingTerms:befaine/heritable disorders/nuclear magnetic resonance/metabolic screening/5-oxoprolinuria/lacta fe/amino acids Proton nuclear magnetic resonance ('H-NMR) spectroscopy has been used to measure metabolites, drugs, and toxic agents in body fluids (1, 2). The technique is potentiallynondestructiveto the samples and requires little or no sample pretreatment.
Because it includes no derivatization or extraction step, the technique is characteristically nonselective.
However, it provides an overview of the quantitatively most important H-containing substances in the sample (3,4 these samples were pretreated essentially as described above (protein removal by ultraffitration). Figure 1 shows a spectrum of a fourfold-concentrated plasma sample from an apparently healthy man. Assignments for resonances in the spectrum were made after two-dimensional-correlated spectroscopy (results not shown) and measuring of various standard solutions (Table 1) . Table 1 Ui, U2, etc.,resonancesfromunknown metabolites. NumberofpatientsIn whom the unknownresonancewas detected is givenin parentheses.
Results

Normal Plasma Spectrum
Onlythe mostImportantsignals are shown.
nine resonances (3.05 and 3.13 ppm, respectively). (Fig. 2) . The results in deproteiniz&jsamples were somewhat higher (median 4.9%) than in the samples not deproteinized-a difference probably accounted for by the volume of the protein. The correlation (12) between the enzymatic assay (with deproteinization) and the NMR data for nine samples (range 0.9-9.2 mmolIL) is described by the regression line y = 0.90x (95% confidence interval 0.85-1.09) + 0.27 (-0.6 to 0.5) mmol/L.
Reproducibility.
Analytical reproducibffity was studied by measuring the 2.7 ppm singlet resonance of succinate.
At 64 scans per measurement, we obtained 128 ± 12 mol/L (mean ± SD, CV 9.3%) in 10 separate measurements of this sample. Using 132 scans, we found 127 ± 7 j.unol/L (n = 10, CV 5%). For 1.2 mmolfL alanine, the CV was 5.1% with 64 scans and 2.5% with 132 scans. Consequently, allfurther data were collected with 132 scans.
For correct interpretation of spectra the use of a library of relevant metabolites is required. Correct assigninentof resonances depends heavily on the intersample reproducibility of the resonance positions. The pH of the sample in the spectrometer is critical and has therefore been closely standardized in our protocol. In 14 random plasma samples we found the following mean Table 1 , citrate has the most variable chemical shift.
Detection limit. The correlation study for alanine and threonine illustrates the sensitivity of the NMR technique, given the good correlation with amino acid analysis over a concentration range of 80-700 mol/L. The detection limit depends on the number of equivalent protons that contribute to a resonance and on the multiplicity of the resonance.
Instrumental and methodological characteristics, e.g., field strength, number of scans, and concentration factor, also determine the sensitivity. Assuining that a signal can be discriminated from the noise if the signal/noise ratio is 3, we determined the detection limit for the methyl-group doublet of threonine as 10 jimol/L. From this value, one can calculate the detection limit for other metabolites. Table 2 shows the estimated detectionlimits for other resonance types for unconcentrated samples under the conditions described in this study, and indudes examples for relevant metabolites for the study of inborn errors of metabolism.
The detection limits given are valid for all metabolites with a given resonance structure.
The detection limit for lactate can therefore also be used for (e.g.) alanine.
Interpretation of Spectra
For proper interpretation of the spectra, one must consider the influence of the patient's diet (3), the medication used, and the effects of age and sex. In very young children pre-or dysmaturity may influence the results (14) . Data on the influence of these factors on many of the metabolites in Table 1 are available in the literature and are beyond the scope of this paper. we observed a high-resonance doublet at 1.13 ppm, which at first was explained as 2-oxoisovaleriate, a metabolite normally present in low concentration in many plasma samples. By measuring the J-coupling of this doublet and noting also the presence of the additional AB-system at 3.48 ppm, we found that these resonances were from propylene glycol, a carrier vehicle in some medications.
Another difficult interpretation of the plasma spectrum involved two brothers with a similar clinical picture. They had similar plasma NMR spectra, which were governed by very high resonances from the mannitol being infused into both children.
Inherited Metabolic Disease
As an example of the diagnostic power of the technique, Fig. 3 shows a (Fig. 3A) are obvious in this patient's plasma by age 8 days (Fig. 3B) . We confirmed the identity of this compound by gas chromatography/mass spectrometry; by adding an extra amount of 5-oxoproline to the plasma of this patient and measuring the NMR spectrum;
and by two-dimensional-correlated spectroscopy. The correlated spectroscopy NMR nicely illustrated the coupling of resonance peak complexes (data not shown). 
Discussion
The partialinvisibility of several metabolites, e.g., lactate (10), some other carboxylic acids (10), and aromatic amino acids (11), in plasma subjected to NMR spin-echo techniques has severely inhibited clinical applications of 'H-NMR. We have shown that simple removal of protein by ifitration provides an alternative that allows standard single-pulse 'H-NMR measurements of several metabolites (lactate, alanine, threonine, and tyrosine), with good correlation with conventional techniques.
In e.g., the aC-proton of methyhnalonic acid exchanges, causing the 3.50 ppm quartet to disappear and the methyl-group doublet (1.37 ppm) to change into a singlet (1.37 ppm), which serves as the only fingerprint of methylmalonic acid in the spectrum.
Furthermore, removal of H20 from the plasma ultrafiltrate before reuptake in D20 also removes more-volatile compounds (e.g., acetone or ethanol) from the sample. However, we are convinced that the quality of the single-pulse spectrum after removal of protein and H20 from the sample is better than that of the spin-echo spectra commonly used for plasma samples. Almost all H-containing metabolites will appear in the spectrum if their concentration is great enough. For most metabolites the detection limit in unconcentrated plasma samples by our method varies between 2 and 40 mol/L, depending on the number of contributing protons and on the multiplicity of the resonance (Table 2) . Of interest for the study of inborn errors of metabolism, the spectrum contains quantitative information on such important metabolites as creatine, dimethylglycine, and betaine, which are not measured by the conventional techniques used for screening for these diseases. The spectrum may also indicate abnormal concentrations of metabolites not known to be related to an inborn error of metabolism.
However, the nonselective character of the technique demands thorough knowledge of the resonances that derive from medication. Knowledge on this aspect is still limited, and further studies are required.
To our knowledge,
'H-NMR data on serum or plasma samples from patients with inborn errors of metabolism have not been published-probably because of the technical limitations described above. The case of the child with 5-oxoprolinuria illustrates that 'H-NMR spectroscopy in plasma samples may be used diagnostically in children with inborn errors of metabolism. Although this particular diagnosis can easily be established by analysis of urine with conventional techniques, the use of 'H-NMR spectroscopy in studies of metabolites in plasma from patients with inborn errors of metabolism seems promising. We have used plasma and not urine in this metabolic study because the many more resonances in the urinary NMR spectra make interpretation of results more difficult. By providing an overall view on all H-containing substances present in the sample in quantities surpassing the detection limit, the technique may bring new perspectives to the study of inherited metabolic disease.
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